Oncotarget recently #published this #trendingwithimpact review: “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability." https://t.co/V1RSfiuSo3 #cancer #chemo #o
#TrendingWithImpact: On December 12, 2023, researchers in Brazil published a new review in Oncotarget: “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability” DOI:
Oncotarget recently #published this #trendingwithimpact review: “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability." https://t.co/V1RSfiuSo3 #cancer #chemo #o
RT @Oncotarget: NEW #PaperoftheDay: "Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: B…
NEW #PaperoftheDay: "Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability" DOI: https://t.co/V1RSfiuSo3 #cancerresearch #oncology #MedEd